Le Lézard
Classified in: Ebola virus, Health, Business
Subject: ERN

ZINZINO AB (PUBL): INTERIM REPORT FIRST QUARTER 2023


GOTHENBURG, Sweden, May 12, 2023 /PRNewswire/ -- HIGH SALES GROWTH AND STRONG PROFITABILITY IN THE FIRST QUARTER

Revenues during the first quarter of 2023 amounted to SEK 393.7 (334.4) million, which corresponded to 18% (0%) growth compared to the corresponding period last year. EBITDA increased to SEK 44.4 (25.8) million and the EBITDA margin increased to 11.3% (7.7%), which showed that the company has managed to increase profitability through efficiency and economies of scale despite high inflation and great uncertainty around the world. During the quarter, there was also the start of sales in Turkey and the launch of new digital tools for the company's distributors in Scandinavia.

JANUARY-MARCH

Link to the report:
https://www.zinzino.com/site/SE/sv-SE/om-oss/investerare/

For more information please contact:

Dag Bergheim Pettersen
CEO Zinzino
+47 (0) 932 25 700,
email: [email protected]

Fredrik Nielsen
CFO Zinzino
+46 707 900 174,
email: [email protected]

Images for free publication:
[email protected]

Certified Adviser: Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: [email protected]

This information is information that Zinzino AB (publ) is obliged to make public according to the EU's market abuse regulation. The information was provided by the above contact person for publication at 08.00 on 12 May 2023.

The following files are available for download:

https://mb.cision.com/Main/10976/3768528/2056557.pdf

Interim Report Q1 2023

https://mb.cision.com/Public/10976/3768528/972cd6466c2b5b6d.pdf

Press Release Zinzino Interim Report Q1 2023

 


These press releases may also interest you

21 mar 2019
The "Europe Welding Equipment Market-Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering. Welding is one of the critical processes employed in the manufacturing...

21 mar 2019
Inovio Pharmaceuticals, Inc. announced today that its Ebola vaccine, INO-4201, was safe, tolerable, and generated strong T cell and antibody responses. This Phase 1 data was published in The Journal of Infectious Diseases and further supports the...

20 mar 2019
Merck , known as MSD outside the United States and Canada, and NGM Biopharmaceuticals, Inc. (NGM) today announced that Merck has exercised its option to extend the research phase of the companies' broad, strategic collaboration...

20 mar 2019
The shareholders in Sandvik Aktiebolag are convened to the Annual General Meeting to be held on Monday, 29 April 2019 at 3:00 p.m. at the Göransson Arena, Sätragatan 21, Sandviken, Sweden. RIGHT TO PARTICIPATE AND NOTICE Shareholders who wish to...

20 mar 2019
The Oslo Business for Peace Award is given to inspiring business leaders who have put society first. 2019's winners are: Dr Agbor Ashumanyi Ako, medical director of GiftedMom, Alice Laugher, CEO of Committed to...

19 mar 2019
The evolving competitive market has made it essential for the telecommunication industry to rethink traditional ways of doing business in terms of the impact on business models, service portfolios and technical architectures. Digital business support...



News published on and distributed by: